Covidien Ltd Launches Three Access Products in Europe for Advanced Minimally Invasive Procedures

NORTH HAVEN, Conn.--(BUSINESS WIRE)--Covidien (NYSE: COV, BSX: COV), a leading global provider of healthcare products, today announced that its Surgical Devices business unit has launched three new access products in Europe, VersaStep™ Plus 15mm, Visiport™ Plus with fixation and Versaport™ Plus RPF 15mm with fixation. The European launch follows the United States introduction of all three products earlier this month.

Back to news